Literature DB >> 19963411

Congenital imperforate hymen with hydrocolpos and hydronephrosis associated with severe hydramnios and increase of maternal ovarian steroidogenic enzymes.

Emmanouil Karteris1, Helen Foster, Maria Karamouti, Anastasia Goumenou.   

Abstract

STUDY
OBJECTIVE: To study clinical features of patient presented with severe hydramnios, associated with hydronephrosis, that was antenatally diagnosed and has been successfully treated immediately after birth. At a molecular level, we investigated the gene expression of key steroidogenic enzymes from the maternal ovary.
DESIGN: Ultrasound scan, MRI, semi-quantitative RT-PCR
SETTING: The patient was admitted to the University Hospital, University of Crete, Medical School, Greece, where all clinical data has been obtained. Gene expression studies took place at Biosciences, Brunel University, UK.
RESULTS: Semi-quantitative RT-PCR analyses revealed that there is upregulation of key steroidogenic genes in the maternal ovary, including steroidogenic acute regulatory protein, and the cytochrome P450 heme-containing proteins CYP11A, CYP17 and CYP19. From a clinical perspective, the prenatal ultrasound scan and MRI findings showed a multicystic pelvic mass, bilateral hydronephrosis and prior to delivery severe polyhydramnios.
CONCLUSION: This clinical case is the only one that we have found in the current literature where congenital imperforate hymen accompanied with hematocolpos is associated with renal obstruction in combination with polyhydramnios and increase in maternal steroidogenic enzymes. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963411     DOI: 10.1016/j.jpag.2009.10.002

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  1 in total

1.  Successful management of giant hydrocolpos in a limited-resource setting.

Authors:  Giulia Reggiani; Damiano Pizzol; Daniele Trevisanuto; Mario Antunes
Journal:  Oxf Med Case Reports       Date:  2018-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.